{"id":516334,"date":"2021-07-22T08:04:24","date_gmt":"2021-07-22T12:04:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/"},"modified":"2021-07-22T08:04:24","modified_gmt":"2021-07-22T12:04:24","slug":"zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/","title":{"rendered":"Zogenix to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5"},"content":{"rendered":"
\n

EMERYVILLE, Calif., July 22, 2021 (GLOBE NEWSWIRE) — Zogenix\u00a0(NASDAQ: ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today announced that it will report its financial results for the second quarter ended June 30, 2021 and host a corporate update conference call and webcast after the market close on Thursday, August 5, 2021, at 4:30 PM Eastern Time.<\/p>\n\n\n\n\n\n\n\n
\n Conference Call Details<\/strong>\n <\/td>\n<\/tr>\n
\n
\n Thursday, August 5, at\u00a04:30 PM Eastern Time\u00a0\/\u00a01:30 PM Pacific Time<\/em>
\n <\/strong>\n <\/td>\n<\/tr>\n
Toll Free:\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/td>\n800-347-6311<\/td>\n<\/tr>\n
International:\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/td>\n323-994-2131<\/td>\n<\/tr>\n
Conference ID:\u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/td>\n6229003<\/td>\n<\/tr>\n
Webcast:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/td>\n\n
\n http:\/\/public.viavid.com\/index.php?id=145894<\/u>
\n <\/a>\n <\/td>\n<\/tr>\n<\/table>\n

\n About Zogenix
<\/strong>Zogenix is a global biopharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives of patients and their families living with rare diseases. The company\u2019s first rare disease therapy, FINTEPLA\u00ae<\/sup> (fenfluramine) oral solution, has been approved by the U.S. FDA and the European Medicines Agency and is in development in Japan for the treatment of seizures associated with Dravet syndrome, a rare, severe lifelong epilepsy. The company has two additional late-stage development programs: one in a rare epilepsy called Lennox-Gastaut syndrome and one in a mitochondrial disease called TK2 deficiency. Zogenix also plans to initiate a study of FINTEPLA in a genetic epilepsy called CDKL5 Deficiency Disorder (CDD) and is collaborating with Tevard Biosciences to identify and develop potential next-generation gene therapies for Dravet syndrome and other genetic epilepsies.<\/p>\n

\n CONTACTS:<\/strong>\n <\/p>\n

\n Zogenix<\/u>
\n
Melinda Baker
Senior Director, Corporate Communications
+1 (510) 788-8732 |\u202fcorpcomms@zogenix.com<\/a><\/p>\n

\n Investors<\/u>
\n
Brian Ritchie\u00a0
Managing Director, LifeSci Advisors LLC
+1 (212) 915-2578 |\u202fbritchie@lifesciadvisors.com<\/a><\/p>\n

\n Media<\/u>
\n
Trish McCall
Porter Novelli
+1 (805) 390-3279
trish.mcall@porternovelli.com<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

EMERYVILLE, Calif., July 22, 2021 (GLOBE NEWSWIRE) — Zogenix\u00a0(NASDAQ: ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today announced that it will report its financial results for the second quarter ended June 30, 2021 and host a corporate update conference call and webcast after the market close on Thursday, August 5, 2021, at 4:30 PM Eastern Time. Conference Call Details Thursday, August 5, at\u00a04:30 PM Eastern Time\u00a0\/\u00a01:30 PM Pacific Time Toll Free:\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 800-347-6311 International:\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 323-994-2131 Conference ID:\u00a0 \u00a0 \u00a0 \u00a0\u00a0 6229003 Webcast:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 http:\/\/public.viavid.com\/index.php?id=145894 About ZogenixZogenix is a global biopharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives … <\/p>\n

Continue reading “Zogenix to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-516334","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nZogenix to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zogenix to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"EMERYVILLE, Calif., July 22, 2021 (GLOBE NEWSWIRE) — Zogenix\u00a0(NASDAQ: ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today announced that it will report its financial results for the second quarter ended June 30, 2021 and host a corporate update conference call and webcast after the market close on Thursday, August 5, 2021, at 4:30 PM Eastern Time. Conference Call Details Thursday, August 5, at\u00a04:30 PM Eastern Time\u00a0\/\u00a01:30 PM Pacific Time Toll Free:\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 800-347-6311 International:\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 323-994-2131 Conference ID:\u00a0 \u00a0 \u00a0 \u00a0\u00a0 6229003 Webcast:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 http:\/\/public.viavid.com\/index.php?id=145894 About ZogenixZogenix is a global biopharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives … Continue reading "Zogenix to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-22T12:04:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDY2NCM0MzA4ODY2IzUwMDA2NzQ2MQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Zogenix to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5\",\"datePublished\":\"2021-07-22T12:04:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\\\/\"},\"wordCount\":268,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NDY2NCM0MzA4ODY2IzUwMDA2NzQ2MQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\\\/\",\"name\":\"Zogenix to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NDY2NCM0MzA4ODY2IzUwMDA2NzQ2MQ==\",\"datePublished\":\"2021-07-22T12:04:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NDY2NCM0MzA4ODY2IzUwMDA2NzQ2MQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NDY2NCM0MzA4ODY2IzUwMDA2NzQ2MQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zogenix to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zogenix to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/","og_locale":"en_US","og_type":"article","og_title":"Zogenix to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5 - Market Newsdesk","og_description":"EMERYVILLE, Calif., July 22, 2021 (GLOBE NEWSWIRE) — Zogenix\u00a0(NASDAQ: ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today announced that it will report its financial results for the second quarter ended June 30, 2021 and host a corporate update conference call and webcast after the market close on Thursday, August 5, 2021, at 4:30 PM Eastern Time. Conference Call Details Thursday, August 5, at\u00a04:30 PM Eastern Time\u00a0\/\u00a01:30 PM Pacific Time Toll Free:\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 800-347-6311 International:\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 323-994-2131 Conference ID:\u00a0 \u00a0 \u00a0 \u00a0\u00a0 6229003 Webcast:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 http:\/\/public.viavid.com\/index.php?id=145894 About ZogenixZogenix is a global biopharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives … Continue reading \"Zogenix to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-22T12:04:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDY2NCM0MzA4ODY2IzUwMDA2NzQ2MQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Zogenix to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5","datePublished":"2021-07-22T12:04:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/"},"wordCount":268,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDY2NCM0MzA4ODY2IzUwMDA2NzQ2MQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/","name":"Zogenix to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDY2NCM0MzA4ODY2IzUwMDA2NzQ2MQ==","datePublished":"2021-07-22T12:04:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDY2NCM0MzA4ODY2IzUwMDA2NzQ2MQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDY2NCM0MzA4ODY2IzUwMDA2NzQ2MQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zogenix-to-release-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Zogenix to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/516334","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=516334"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/516334\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=516334"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=516334"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=516334"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}